Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Therapy With Herceptin and Taxol for Stage II/III Breast Cancer

NCT00136539 is registered in ClinicalTrials.gov with Harold J. Burstein, MD, PhD as lead sponsor.

NCT NCT00136539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00136539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Therapy With Herceptin and Taxol for Stage II/III Breast Cancer
Lead sponsor
Harold J. Burstein, MD, PhD
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1999
Completion date
March 31, 2012
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer